MHRA approves zuranolone to treat postnatal depression in adults following childbirth
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved zuranolone (brand name: Zurzuvae) to treat moderate or severe postnatal...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved zuranolone (brand name: Zurzuvae) to treat moderate or severe postnatal...